MarketInOut Stock Screener Log In | Sign Up

IDT Australia Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/29/2026 15:52
IDT Australia Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization16.33 mln
Float352 mln
Earnings Date02/23/2027

Piotroski F-Score

5 / 9
Neutral

Relative Strength

94 / 100
Top performer

Debt / Equity

0.57
Moderate leverage

Pre-Tax Margin

-13%
Loss-making

ROE

-13.31
Negative

Altman Z-Score

-0.89
Deeply distressed

Business Description

Founded in 1975 and based in Boronia, Australia, IDT Australia Limited is a pharmaceutical company that develops, manufactures, and sells drug ingredients and finished medicines across Australia, Asia, Europe, and the United States. The company covers a broad range of products and services, including medicinal cannabis, psychedelics, injectable solutions, mRNA therapies, antibody drug conjugates, and oral medications, as well as testing, clinical packaging, and pharmacy support. IDT also produces medicines on behalf of other companies through contract manufacturing arrangements.

Key Fundamentals

EPS-0.01
ROE-13.31
RPS0.05
ROIC-5.06
ROA-7.66
Interest Cover-1.31
EBITDA, mln-0.54
EV / EBITDA-50.96
EV / EBIT-19.07
Revenue, mln20.36
EV / Revenue1.35

Quote Details

Last 0.045
Change -0.003 (-6.25%)
Open 0.045
Volume 652,065
Turnover 29,343
Average Volume 269,431

Financial Ratios

Pre-Tax Profit Margin-13
Leverage Ratio1.83
Current Ratio2.33
Price / Book1.00
Price / Tangible Book0.90
Price / Cash Flow15.11
Debt / Equity0.57
Price / Sales0.94
PEG Ratio2.75

Financial Strength

Altman Z-Score-0.89
Piotroski F-Score 5 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 18.42% 98 / 100   
1 Month 0% 65 / 100   
2 Months 36.36% 96 / 100   
6 Months 12.5% 86 / 100   
1 Year -23.73% 33 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog